Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H31F3N4O3S |
InChIKeyPMTLKNOARSHUJB-ZJSXRUAMSA-N |
CAS Registry1449578-65-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 16 Aug 2013 |